Logo image of MRD.CA

MELCOR DEVELOPMENTS LTD (MRD.CA) Stock Fundamental Analysis

Canada - TSX:MRD - CA5854671032 - Common Stock

14.52 CAD
-0.26 (-1.76%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

5

MRD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 29 industry peers in the Real Estate Management & Development industry. While MRD has a great health rating, its profitability is only average at the moment. MRD has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year MRD was profitable.
In the past year MRD had a positive cash flow from operations.
Each year in the past 5 years MRD has been profitable.
MRD had a positive operating cash flow in each of the past 5 years.
MRD.CA Yearly Net Income VS EBIT VS OCF VS FCFMRD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

With a Return On Assets value of 0.48%, MRD perfoms like the industry average, outperforming 51.72% of the companies in the same industry.
The Return On Equity of MRD (0.78%) is comparable to the rest of the industry.
MRD has a Return On Invested Capital of 5.20%. This is in the better half of the industry: MRD outperforms 68.97% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MRD is significantly below the industry average of 11.82%.
The last Return On Invested Capital (5.20%) for MRD is above the 3 year average (3.82%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.48%
ROE 0.78%
ROIC 5.2%
ROA(3y)2.91%
ROA(5y)2.39%
ROE(3y)5.16%
ROE(5y)4.32%
ROIC(3y)3.82%
ROIC(5y)3.63%
MRD.CA Yearly ROA, ROE, ROICMRD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

1.3 Margins

The Profit Margin of MRD (2.54%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of MRD has declined.
The Operating Margin of MRD (37.62%) is better than 75.86% of its industry peers.
MRD's Operating Margin has improved in the last couple of years.
The Gross Margin of MRD (47.53%) is comparable to the rest of the industry.
MRD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 37.62%
PM (TTM) 2.54%
GM 47.53%
OM growth 3Y0.63%
OM growth 5Y5.89%
PM growth 3Y-18.68%
PM growth 5Y-11.95%
GM growth 3Y0.48%
GM growth 5Y-0.66%
MRD.CA Yearly Profit, Operating, Gross MarginsMRD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

MRD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MRD has less shares outstanding
Compared to 5 years ago, MRD has less shares outstanding
MRD has a better debt/assets ratio than last year.
MRD.CA Yearly Shares OutstandingMRD.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MRD.CA Yearly Total Debt VS Total AssetsMRD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

MRD has an Altman-Z score of 1.62. This is a bad value and indicates that MRD is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 1.62, MRD is doing good in the industry, outperforming 62.07% of the companies in the same industry.
The Debt to FCF ratio of MRD is 4.52, which is a neutral value as it means it would take MRD, 4.52 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 4.52, MRD belongs to the best of the industry, outperforming 86.21% of the companies in the same industry.
MRD has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
MRD's Debt to Equity ratio of 0.49 is fine compared to the rest of the industry. MRD outperforms 72.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 4.52
Altman-Z 1.62
ROIC/WACC0.7
WACC7.4%
MRD.CA Yearly LT Debt VS Equity VS FCFMRD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

MRD has a Current Ratio of 4.32. This indicates that MRD is financially healthy and has no problem in meeting its short term obligations.
MRD has a Current ratio of 4.32. This is amongst the best in the industry. MRD outperforms 86.21% of its industry peers.
A Quick Ratio of 4.32 indicates that MRD has no problem at all paying its short term obligations.
MRD has a better Quick ratio (4.32) than 86.21% of its industry peers.
Industry RankSector Rank
Current Ratio 4.32
Quick Ratio 4.32
MRD.CA Yearly Current Assets VS Current LiabilitesMRD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2

3. Growth

3.1 Past

MRD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.78%.
The Earnings Per Share has been decreasing by -0.67% on average over the past years.
The Revenue has grown by 14.26% in the past year. This is quite good.
The Revenue has been growing by 10.94% on average over the past years. This is quite good.
EPS 1Y (TTM)-88.78%
EPS 3Y-13.69%
EPS 5Y-0.67%
EPS Q2Q%-68.66%
Revenue 1Y (TTM)14.26%
Revenue growth 3Y3.46%
Revenue growth 5Y10.94%
Sales Q2Q%43.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-5.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRD.CA Yearly Revenue VS EstimatesMRD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
MRD.CA Yearly EPS VS EstimatesMRD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 51.86, MRD can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of MRD is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.40. MRD is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 7.22 indicates a rather cheap valuation of MRD.
Based on the Price/Forward Earnings ratio, MRD is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.94. MRD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 51.86
Fwd PE 7.22
MRD.CA Price Earnings VS Forward Price EarningsMRD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

MRD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MRD is cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MRD is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.29
EV/EBITDA 6.6
MRD.CA Per share dataMRD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of MRD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

MRD has a Yearly Dividend Yield of 3.52%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.39, MRD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, MRD pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.52%

5.2 History

The dividend of MRD decreases each year by -2.57%.
MRD has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-2.57%
Div Incr Years0
Div Non Decr Years0
MRD.CA Yearly Dividends per shareMRD.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

137.86% of the earnings are spent on dividend by MRD. This is not a sustainable payout ratio.
The Dividend Rate of MRD has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP137.86%
EPS Next 2YN/A
EPS Next 3YN/A
MRD.CA Yearly Income VS Free CF VS DividendMRD.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M
MRD.CA Dividend Payout.MRD.CA Dividend Payout, showing the Payout Ratio.MRD.CA Dividend Payout.PayoutRetained Earnings

MELCOR DEVELOPMENTS LTD

TSX:MRD (10/17/2025, 7:00:00 PM)

14.52

-0.26 (-1.76%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-14 2025-08-14
Earnings (Next)11-06 2025-11-06
Inst Owners8.76%
Inst Owner ChangeN/A
Ins Owners14.08%
Ins Owner ChangeN/A
Market Cap437.63M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.52%
Yearly Dividend0.44
Dividend Growth(5Y)-2.57%
DP137.86%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-15 2025-09-15 (0.13)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 51.86
Fwd PE 7.22
P/S 1.15
P/FCF 3.29
P/OCF 2.92
P/B 0.35
P/tB 0.35
EV/EBITDA 6.6
EPS(TTM)0.28
EY1.93%
EPS(NY)2.01
Fwd EY13.84%
FCF(TTM)4.41
FCFY30.37%
OCF(TTM)4.97
OCFY34.21%
SpS12.64
BVpS40.98
TBVpS40.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.48%
ROE 0.78%
ROCE 7.22%
ROIC 5.2%
ROICexc 5.43%
ROICexgc 5.6%
OM 37.62%
PM (TTM) 2.54%
GM 47.53%
FCFM 34.89%
ROA(3y)2.91%
ROA(5y)2.39%
ROE(3y)5.16%
ROE(5y)4.32%
ROIC(3y)3.82%
ROIC(5y)3.63%
ROICexc(3y)3.93%
ROICexc(5y)3.72%
ROICexgc(3y)4.06%
ROICexgc(5y)3.84%
ROCE(3y)5.31%
ROCE(5y)5.03%
ROICexcg growth 3Y4.23%
ROICexcg growth 5Y17.72%
ROICexc growth 3Y4.16%
ROICexc growth 5Y17.7%
OM growth 3Y0.63%
OM growth 5Y5.89%
PM growth 3Y-18.68%
PM growth 5Y-11.95%
GM growth 3Y0.48%
GM growth 5Y-0.66%
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 4.52
Debt/EBITDA 4.16
Cap/Depr 1376.95%
Cap/Sales 4.41%
Interest Coverage 250
Cash Conversion 103.58%
Profit Quality 1374.02%
Current Ratio 4.32
Quick Ratio 4.32
Altman-Z 1.62
F-Score7
WACC7.4%
ROIC/WACC0.7
Cap/Depr(3y)1460.36%
Cap/Depr(5y)1587.21%
Cap/Sales(3y)6.3%
Cap/Sales(5y)7.47%
Profit Quality(3y)95.67%
Profit Quality(5y)124.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-88.78%
EPS 3Y-13.69%
EPS 5Y-0.67%
EPS Q2Q%-68.66%
EPS Next Y-5.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.26%
Revenue growth 3Y3.46%
Revenue growth 5Y10.94%
Sales Q2Q%43.66%
Revenue Next Year-3.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.47%
EBIT growth 3Y4.12%
EBIT growth 5Y17.48%
EBIT Next Year-3.66%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6859.32%
FCF growth 3Y18.66%
FCF growth 5Y52.08%
OCF growth 1Y490.1%
OCF growth 3Y10.64%
OCF growth 5Y25.86%